sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Mycosis Fungoides Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00016770
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

2031년까지 균상식육증 치료제 시장 점유율 및 규모 분석

Buy Now

Mycosis Fungoides Therapeutics Market Report Mycosis Fungoides Therapeutics Market Size and Share Mycosis Fungoides Therapeutics Market Scope and Analysis

Mycosis Fungoides Therapeutics Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 8.4%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By 유형
  • 소분자
  • 생물학
By 유통 채널
  • 병원 약국
  • 소매 약국
  • 기타
By 지리
  • 북미
  • 유럽
  • 아시아 태평양
  • 남미 및 중미
  • 중동 및 아프리카
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Azurity Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited
  • Soligenix
  • Seattle Genetics, Inc.
  • Merck & Co., Inc.
  • Kyowa Kirin Co., Ltd.
  • Horizon Therapeutics plc
  • Helsinn Healthcare SA
  • Eisai Co., Ltd.